Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of

Active, not recruitingOBSERVATIONAL
Enrollment

385

Participants

Timeline

Start Date

May 18, 2020

Primary Completion Date

April 30, 2023

Study Completion Date

December 31, 2025

Conditions
Rectal Cancer
Interventions
DIAGNOSTIC_TEST

pelvic MRI for establishing new mrTRG method

they will received two pelvic MR examinations before and after neoadjvant therapy. The MRI before neoadjvant therapy is considered as baseline MRI, which is usually taken within 3 weeks before NAT. The MRI after neoadjvant therapy is considered as preoperative MRI, which is usually taken within 3-8 weeks before NAT.

Trial Locations (3)

100039

Chinese PLA General Hospital, Beijing

100142

Beijing Cancer Hospital, Beijing

Peking University Shougang Hospital, Beijing

All Listed Sponsors
collaborator

Capital's Funds for Health Improvement and Research (2020-1- 2151).

UNKNOWN

lead

Peking University Cancer Hospital & Institute

OTHER

NCT05374044 - Establishment of MRI Model for pTRG in Rectal Cancer With Establishment of | Biotech Hunter | Biotech Hunter